DRI Healthcare Trust (TSX:DHT.UN)
Canada · Delayed Price · Currency is CAD 18.17
-0.02 (-0.11%)
Oct 9, 2026, 4:00 PM EST
DRI Healthcare Trust Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, DRI Healthcare Trust stock has a consensus rating of "Strong Buy" and an average price target of $24.46. The average 1-year stock price forecast is 34.62% higher than the current stock price, while the lowest is $21.78 (+19.87%) and the highest is $27.21 (+49.75%).
Price Target: $24.46 (+34.62%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for DRI Healthcare Trust stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 5 | 5 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $26.00 → $27.00 | Buy | Maintains | $26.00 → $27.00 | +48.60% | Sep 29, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $23.00 | Buy | Maintains | $23.00 | +26.58% | Sep 23, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $21.00 → $22.00 | Buy | Maintains | $21.00 → $22.00 | +21.08% | Sep 22, 2026 |
| National Bank | National Bank | Buy Maintains $23.50 → $25.50 | Buy | Maintains | $23.50 → $25.50 | +40.34% | Sep 22, 2026 |
| CIBC | CIBC | Buy Maintains $21.00 | Buy | Maintains | $21.00 | +15.58% | Aug 11, 2026 |
Financial Forecast
Revenue This Year
194.12M
from 191.81M
Increased by 1.20%
Revenue Next Year
225.25M
from 194.12M
Increased by 16.03%
EPS This Year
2.54
from 2.26
Increased by 12.51%
EPS Next Year
2.82
from 2.54
Increased by 10.84%
EPS and Forward PE are based on non-GAAP adjusted numbers.